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Abstract
Background—Hemorrhagic shock is a leading cause of morbidity and mortality in surgery and 
trauma patients. Despite a large number of preclinical trials conducted to develop therapeutic 
strategies against hemorrhagic shock, there is still an unmet need exist for effective therapy for 
hemorrhage victims. Wnt/β-catenin signaling controls developmental processes and cellular 
regeneration owing to its central role in cell survival and proliferation. We therefore hypothesized 
that the activation of Wnt signaling reduces systemic injury caused by hemorrhagic shock.
Methods—Adult male Sprague-Dawley rats underwent hemorrhagic shock by controlled 
bleeding of the femoral artery to maintain a mean arterial pressure (MAP) of 30 mmHg for 90 
min, followed by resuscitation with crystalloid equal to two times the shed blood volume. After 
resuscitation, animals were infused with Wnt agonist (5 mg/kg) or Vehicle (20% DMSO in saline). 
Blood and tissue samples were collected 6 h after resuscitation for analysis.
Results—Hemorrhagic shock increased serum levels of AST, lactate, and LDH. Treatment with 
Wnt agonist significantly reduced these levels by 40%, 36%, and 77%, respectively. Wnt agonist 
also decreased BUN and creatinine by 34% and 56%, respectively. Treatment reduced lung 
myeloperoxidase activity and IL-6 mRNA by 55% and 68% respectively and, significantly 
improved lung histology. Wnt agonist treatment increased Bcl-2 protein to Sham values and 
decreased cleaved caspase-3 by 46% indicating attenuation of hemorrhage-induced apoptosis in 
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the lungs. Hemorrhage resulted in significant reductions of β-catenin protein levels in the lungs as 
well as down-regulation of a Wnt target gene, Cyclin-D1, while Wnt agonist treatment preserved 
these levels.
Conclusions—The administration of Wnt agonist attenuated hemorrhage-induced organ injury, 
inflammation and apoptosis. This was correlated with preservation of the Wnt signaling pathway. 
Thus, Wnt/β-catenin activation could be protective in hemorrhagic shock.
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Introduction
Trauma is the fifth leading cause of death overall and the number one cause of death for 
patients below 40 years of age1–3. About 40% of these deaths are due to bleeding1. Despite 
advances in our understanding of the pathophysiology of trauma, there has been little 
improvement in trauma outcome over the past several decades. Although hemorrhage itself 
can be controlled, optimal resuscitation strategy to minimize reperfusion injury and tissue 
damage remains elusive. As such, there is still an unmet need in effective resuscitation 
strategies for hemorrhagic shock.
Hemorrhagic or hypovolemic shock is characterized as a functional alteration of the 
circulatory system. The primary treatment is to address the bleeding and frequently, this 
requires surgical intervention. Replacement of blood loss via fluid resuscitation is used to 
maintain blood pressure and is necessary to continue oxygen delivery to the ischemic 
tissues. The return of oxygen to ischemic tissues, however, initiates reperfusion injury. Early 
in reperfusion, endothelial cells exhibit morphological damage including cellular swelling, 
loss of adherence to basement membrane and adherence of activated leukocytes4. 
Endothelial damage is found throughout the vascular system and the postcapillary venule is 
the common site for inflammatory response due to reperfusion injury. The damaged 
endothelium also produces oxygen radicals such as superoxide and hydrogen peroxide5.
Wnt proteins belong to a family of secreted cysteine-rich glycoproteins. Signaling by Wnt 
proteins is involved in a wide array of developmental and physiological processes while 
dysregulation leads to diseases6–8. Wnt can activate β-catenin dependent (canonical) and 
independent (non-canonical) pathways9,10. The hallmark of the canonical pathway is the 
regulated degradation of β-catenin. In the absence of Wnt, β-catenin is phosphorylated by 
GSK3 and subjected to ubiquitination and proteasomal degradation resulting in a low level 
of cytoplasmic β-catenin. Upon Wnt stimulation, Wnt ligand forms a complex with the cell-
surface receptor Frizzled (Fz) and initiates a cascade of events eventually inhibiting 
proteasomal degradation of β-catenin. The accumulated β-catenin enters the nucleus and 
interacts with transcription factors TCF (T-cell factor)/LEF (lymphoid enhancing factor) to 
activate Wnt target genes (reviewed in11).
Wnt signaling plays a role in vascular endothelial survival and proliferation12,13. The 
compound 2-amino-4-[3,4-(methlyenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine 
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(Wnt agonist) was recently identified as the activator of the Wnt signaling pathway14,15. 
Since hypovolemic shock is characterized as a functional abnormality in the circulatory 
system and that endothelium is the primary target for reperfusion injury, we sought to 
determine whether Wnt agonist could ameliorate organ damage caused by hypovolemia 
associated reperfusion injury.
Materials and Methods
Male Sprague-Dawley (SD) rats weighing 275–325 g were purchased from Charles River 
Laboratories (Wilmington, MA) and used in this study. The rats were housed under 12 h 
light/dark cycle and fed a standard Purina rat chow diet. The rats were fasted for 10 h prior 
to the procedure. Animal experiments were carried out in accordance with the Guide for the 
Care and Use of Laboratory Animals and the project was approved by the Institutional 
Animal Care and Use Committee of the Feinstein Institute for Medical Research.
Animal Model of Hemorrhagic Shock
The model of hemorrhagic shock was previously described in detail by us16–19. Briefly, the 
rats were anesthetized with isoflurane inhalation. The right femoral vein and artery, and the 
left femoral artery were cannulated with PE-50 tubings. Right arterial catheter was used to 
monitor pressure and heart rate via a blood pressure analyzer (BPA; Digi-Med, Louisville, 
KY), the left one was utilized for blood withdrawal. The venous catheter was used for fluid 
resuscitation. The rats were rapidly bled to 30 mm Hg and maintained for 90 min by either 
further withdrawal of blood or infusion of small volumes of Ringer’s lactate. At the end of 
90 min, the rats were resuscitated with two times the shed blood volume in the form of 
Ringer’s lactate (i.e., low-volume resuscitation) over a 60-min period. The shed blood was 
not used for resuscitation and the animals were not heparinized. The Sham animals 
underwent the same surgical procedure but were not bled or resuscitated.
Administration of Wnt Agonist
At 15 min after the initiation of resuscitation, 1 ml Vehicle (20% Dimethyl sulfoxide 
[DMSO] in normal saline) or Wnt agonist (5 mg/kg BW in Vehicle) was infused through the 
femoral vein catheter over a period of 45 min. Blood and tissue samples were harvested 4 h 
post-resuscitation (i.e., 6.5 h from the beginning of hemorrhage). Wnt agonist (2-Amino-4-
(3,4-(methylenedioxy) benzylamino)-6-(3-methoxyphenyl)pyrimidine) was purchased from 
Calbiochem, San Diego, CA).
Measurement of serum levels of organ injury indicators
Serum concentrations of aspartate aminotransferase (AST), lactate, lactate dehydrogenase 
(LDH), Blood Urea Nitrogen (BUN) and creatinine were determined by using assay kits 
according to manufacturer’s instructions (Pointe Scientific, Lincoln Park, MI).
Lung histology
Lung tissues were fixed in 10% buffered formalin and embedded in paraffin. The tissue 
blocks were cut into 5 µm sections, transferred to glass slides, stained with hematoxylin and 
eosin, dehydrated and mounted. Morphologic examinations were performed by using light 
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microscopy. Lung injury was assessed as absent, mild, moderate or severe injury (score 0–3) 
based on previously published criteria20,21.
Lung MPO activity
Lung tissues were homogenized in KPO4 buffer containing 0.5% hexa-decyl-trimethyl-
ammonium bromide. Upon centrifugation, supernatant was measured of MPO activity as 
previously described22,23.
Lung IL-6 mRNA expression
Total RNA was extracted from the lungs using Tri-Reagent (Molecular Research Center, 
Cincinnati, OH). RNA (4 µg) was reverse-transcribed and analyzed by real time PCR using 
primers specific for rat IL-6 (NM_012589). Rat glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was used as the housekeeping gene. The primer sequences are the following: IL-6 
forward: 5’-AGG GAG ATC TTG GAA ATG AGA AAA-3’ and reverse: CAT CAT CGC 
TGT TCA TAC AAT CAG-3’; GAPDH forward: 5’-ATG ACT CTA CCC ACG GCA 
AG-3’ and reverse: 5’-CTG GAA GAT GGT GAT GGG TT-3’. Each cycle consisted of 30 
sec at 94°C, 30 sec at 60°C, and 45 sec at 72°C.
Western blotting
Lung tissues were homogenized in lysis buffer containing protease inhibitors. The extracted 
protein (50 µg) were fractionated on a Bis-Tris gel and transferred to 0.2 µm nitrocellulose 
membrane. The membranes were blocked and incubated overnight with rabbit polyclonal 
cleaved caspase-3 (Cell Signaling, Danvers, MA), rabbit polyclonal Bcl-2, mouse 
monoclonal β-catenin or mouse monoclonal cyclin D1 antibodies (Santa Cruz Biotech, 
Dallas, TX). The membranes were then incubated with horseradish peroxidase-labeled 
secondary antibodies, reacted with chemiluminiscence, exposed to radiograph film and band 
densities were determined using NIH ImageJ software. The bands were normalized against 
β-actin protein levels.
Statistical analysis
All data are expressed as mean ± SE and analyzed by one way analysis of variance 
(ANOVA) and compared using Student Newman Keul’s (SNK) test for multiple 
comparisons. The differences in values were considered significant if P < 0.05.
Results
Wnt agonist attenuated tissue damage following hemorrhagic shock
As shown in Figure 1, hemorrhagic shock significantly increased serum levels of AST, 
lactate and LDH by 658%, 121% and 840% respectively, as compared to sham-operated 
animals. Wnt agonist decreased these levels by 40%, 36% and 77%, respectively (Figures 
1A–C). Hemorrhagic shock also increased serum levels of BUN and creatinine by 260% and 
200%, respectively. Treatment with Wnt agonist decreased them by 34% and 56%, 
respectively (Figures 1C–D). Treatment with Wnt agonist during resuscitation in 
hemorrhagic shock reduced tissue damage and preserved renal function.
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Wnt agonist reduced lung injury and inflammation following hemorrhagic shock
As shown in Figure 2A, vehicle treated animals following hemorrhagic shock presented with 
edema, tissue infiltration, intralveolar hemorrhage and debris, neutrophil margination, 
hyperemia and congestion, and cellular hyperplasia in the lungs. Treatment with Wnt 
agonist significantly improved lung architecture. Lung injury score was markedly increased 
after hemorrhagic shock and treatment with Wnt agonist reduced these levels by 46% 
(Figure 2B). As a measure of inflammation, lung IL-6 mRNA expression (tissue cytokine 
expression) and MPO activity (tissue neutrophil infiltration) were analyzed following 
treatment with Wnt agonist during hemorrhagic shock. The lung IL-6 mRNA was increased 
by 93-fold after hemorrhagic shock and treatment with Wnt agonist decreased it by 68% 
(Figure 3A). The lung MPO activity was also increased by 14-fold after hemorrhagic shock 
and treatment decreased it by 55% (Figure 3B).
Wnt agonist attenuated apoptosis in the lungs and preserved Wnt/β-catenin signaling 
following hemorrhagic shock
In the vehicle treated animals after hemorrhagic shock, cleaved caspase-3 was increased by 
5.5-fold whereas treatment with Wnt agonist significantly attenuated these levels by 46% 
(Figure 4A). On the other hand, Bcl-2 was markedly decreased by 35% in vehicle treated 
animals while significantly increased with Wnt agonist treatment and restored to sham 
values (Figure 4B). Both β-catenin and cyclin D1 in the lungs were significantly decreased 
while Wnt agonist markedly preserved these levels (Figure 5A–B).
Wnt agonist did not alter mean arterial pressure from vehicle following hemorrhagic shock
In hemorrhaged animals, resuscitation with two times the shed blood volume of Ringer’s 
lactate (i.e., low volume resuscitation) significantly increased the mean arterial pressure 
(MAP). Interestingly, Wnt agonist treatment did not significantly alter the MAP from the 
vehicle group during the observation period of 140 min from the initiation of hemorrhage. 
These data indicate that the mechanism of its action in hemorrhagic shock is not at the 
hemodynamic parameter level (Figure 6).
Discussion
The first sign of hypovolemic shock is a decrease in blood pressure. Compensatory 
mechanisms such as catecholamine release are able to maintain blood pressure and 
redistribute cardiac output to sustain the vital organs such as the heart and brain24. However, 
these compensatory mechanisms are limited and without interventions, severe cellular 
hypoxia and organ damage occur leading to multi organ failure and death25. While fluid 
resuscitation is effective in maintaining blood pressure and reoxygenation of cells and 
tissues, it leads to reperfusion injury and tissue damage. In the current study we showed that 
in hemorrhagic shock, administration of Wnt agonist during resuscitation attenuated 
systemic injury as evidenced by the significant decrease in the serum markers of liver 
enzymes, lactate, LDH, BUN and creatinine. The treatment also improved lung architecture, 
and reduced neutrophil infiltration to the lungs, IL-6 expression, and apoptosis markers. We 
also demonstrated that these protective effects of Wnt agonist were mediated by the Wnt/β-
catenin pathways possibly via cyclin D1 gene expression.
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The canonical Wnt pathway is featured by the regulated degradation of β-catenin. The β-
catenin destruction complex is consisted of glycogen synthase kinase (GSK) 3α and 3 β, 
Casein Kinase 1, Adenomatous Polyposis, the scaffold protein Axin and transcription co-
factor β-catenin. Upon Wnt stimulation, Wnt ligand forms a complex with the cell-surface 
receptor Frizzled (Fz) and initiates a cascade of events eventually inhibiting proteasomal 
degradation of β-catenin. The accumulated β-catenin enters the nucleus and interacts with 
transcription factors TCF (T-cell factor)/LEF (lymphoid enhancing factor) to activate Wnt 
target genes (reviewed in11). One such Wnt target gene is cyclin D1 which is a major 
regulator of the progression of cells into the proliferative stage of the cell cycle26,27. Our 
study showed that hemorrhagic shock significantly decreased beta-catenin protein in the 
lungs while treatment with Wnt agonist increased these levels during resuscitation. We also 
observed downregulation of Wnt target gene cyclin D1 after hemorrhagic shock and 
treatment with Wnt agonist increased cyclin D1 during resuscitation. These data suggest that 
Wnt signaling is disrupted in hemorrhagic shock and Wnt agonist was able to preserve the 
Wnt/β-catenin signaling.
Several reports point to the role of Wnt activation in modulating inflammatory responses. 
Wnt activation by Wnt2, one of the Wnt ligands, contributed to host protection in response 
to enteric bacteria by affecting signaling pathways related to cell proliferation and apoptosis 
by modulating inflammatory responses28. Overexpression of Wnt2 lowered IL-8 levels 
induced by bacterial infection in intestinal epithelial cells. Wnt2 signaling led to 
upregulation of β-catenin and promoted viability in intestinal epithelial cells during bacterial 
infection28. Wnt pathway ligand Wnt7b produced by macrophages, stimulated epithelial 
response in injured kidney to reestablish a developmental processes that initiated repair and 
regeneration29. Wnt4, a gene expressed in the developing kidney is re-expressed in the early 
phase of ischemia/reperfusion kidney and plays a key role in transcriptional regulation of 
cyclin D1 and cell cycle progression in renal tubular cells in acute renal failure. Thus, Wnt 
activation regulates inflammation and promotes repair and regeneration of injured tissue.
The mechanism by which Wnt signaling is protective in hemorrhagic shock has not been 
completely determined. Endothelium is the primary site for reperfusion injury caused by 
hemorrhagic shock. Endothelial cells are sensitive to hypoxia and they exhibit 
morphological damages including increase in cellular volumes and loss of cytoskeletal 
organization and decreased membrane fluidity4. The injury is initiated from leukocyte-
endothelial adhesion, transendothelial migration, platelet-leukocyte aggregation and 
enhanced oxidant production5. Reperfusion injury diminishes the ability of mitochondria 
and contributes to reactive oxygen species production30. Mitochondria are also central to 
apoptotic pathways and play a major role in apoptotic cell death31,32. Several studies have 
been reported on the benefit of antioxidants during reperfusion33–35. The effect of nitric 
oxide on the endothelium has been heavily investigated and the current thinking is that the 
constitutively expressed nitric oxide synthase (NOS) is involved in neutrophil adhesion to 
the endothelium whereas the inducible NOS is associated with NF-κB activation and 
subsequent cytokine production36. There is evidence that NF-κB is a key factor of apoptosis 
via cross talk with the known apoptotic genes of the mitogen activated protein kinase 
family37. Studies have shown that Wnt signaling plays a major role in endothelial cell 
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survival and proliferation12,13. It has been shown that MDR1 gene which encodes a p-
glycoprotein expressed in the brain vasculature is a direct target of TCF4/β-catenin 
transcription complex38. In brain endothelial cells, Wnt agonist in vitro enhanced β-catenin 
and increased transcription of protein levels of p-glycoprotein39. It is plausible that Wnt 
agonist protects the endothelium from reperfusion injury via activation of the Wnt target 
genes (i.e., cyclin D1) during hemorrhagic shock.
In embryonic development, the canonical pathway has been associated with cell fate while 
non-canonical pathway has been involved in cellular polarity and cell movements40. In the 
current study, we showed that both β-catenin and cyclin-D1 in the lungs were significantly 
decreased after hemorrhagic shock in the lungs and that Wnt agonist markedly preserved 
these levels and therefore speculated that the canonical pathway is involved in the protective 
effects of Wnt agonist in shock. Future studies are needed to determine the role if any, of the 
non-canonical pathway in this protection.
Our studies indicated that administration of the Wnt agonist during resuscitation does not 
alter MAP from that of the vehicle group indicating that the Wnt agonist action is not at the 
level of improving blood pressure. However, the data clearly indicated that the Wnt agonist 
treatment protected the lungs from hemorrhage induced damage. Although it is not known 
whether Wnt agonist improves cardiovascular responses or remote organ functions in 
addition to the lungs, decrease in serum levels of organ injury markers indicate systemic 
potential benefit of the Wnt agonist after hemorrhagic shock and resuscitation.
Although we have not examined other tissues by histological approach, we measured organ 
injury markers, liver enzymes (AST, ALT), and kidney markers (BUN and creatinine). Wnt 
agonist treatment attenuated all injury markers examined and from this result, we can 
speculate that hemorrhage induced liver injury and kidney dysfunctions were ameliorated 
with Wnt agonist treatment. Likewise, we have shown protective effect of the Wnt agonist 
in the lungs as evidenced by a reduction in lung injury and inflammation as well as a 
decrease in apoptosis in the lungs. All of these effects were correlated with Wnt/β-catenin 
signaling in the lung tissue. Further analyses of the liver, kidneys or gut are needed to 
determine whether the protective effects vary among tissues.
While fixed pressure hemorrhage model used in the current study may limit clinical 
relevance, fixed volume resuscitation is rather beneficial. Fluid overload may lead to 
pulmonary edema, systemic inflammatory response, anemia, thrombocytopenia, electrolyte/
acid-base abnormalities. Administration of excessive fluids increases the odds ratio of acute 
respiratory distress syndrome, pneumonia, multiple organ failure, blood stream infections 
and death. It can be argued that the model doesn’t reflect trauma caused by soft tissue injury. 
However, the model requires the cut down of the blood vessels which mimics tissue trauma. 
The time point chosen, i.e., 6.5 h after hemorrhage to examine the effect of Wnt agonist in 
shock was based on our previous studies where we observed significant alterations in tissue 
injury following hemorrhagic shock41. Future studies will address the long term effects such 
as survival advantage after Wnt agonist treatment in hemorrhagic shock.
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In our hemorrhagic shock model, we did not use shed blood as resuscitation fluid instead we 
used low volume resuscitation with Ringer’s lactate (i.e., crystalloid). This resuscitation 
method was chosen because such fluids are readily available in clinical settings. However 
neither crystalloids nor colloids alone had any major benefit in trauma outcome42–44. Our 
studies suggest that Wnt agonist delivered in low volume crystalloid preserved the Wnt/β-
catenin signaling pathway during resuscitation following hemorrhagic shock and was 
protective from systemic inflammation as well as the injury to the lungs.
In a pilot safety study, sham animals were treated with 5 mg/kg BW Wnt agonist and 
monitored the animals for 24 h. There was neither toxicity nor biological activity observed 
in sham animals. In future studies, in an attempt to develop this compound as a therapy for 
hemorrhagic shock, we will perform dose response studies and conduct the drug normal 
control with the highest dose tested.
In summary, Wnt agonist attenuated hemorrhage-induced systemic inflammation, organ 
injury and lung apoptosis. Wnt/β-catenin signaling is disrupted in hemorrhagic shock and 
Wnt activation preserved the Wnt/β-catenin signaling. Wnt signaling could be a potential 
target for therapy for resuscitation after hemorrhagic shock.
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Figure 1. Changes in serum levels of systemic injury and renal function markers
(A) AST, (B) Lactate, (C) LDH, (D) BUN, (E) Creatinine in Sham, Vehicle and Wnt agonist 
(WntAg)-treated rats at 6 h after hemorrhagic shock. Data are expressed as mean ± SE and 
compared by one-way ANOVA and Student Neuman Keul’s (SNK) test. *P<0.05 vs. Sham 
and #P<0.05 vs. Vehicle.
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Figure 2. Changes in histological appearance of the lung
(A) Representative photographs of lung tissue sections stained with hematoxylin-eosin 
(original magnification ×200) of Sham, Vehicle and Wnt agonist treatment in rats at 6 h 
after hemorrhagic shock. (B) The injury score of the lung tissue sections are shown. Data are 
expressed as mean ± SE and compared by one-way ANOVA and SNK test. *P<0.05 vs. 
Sham and #P<0.05 vs. Vehicle.
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Figure 3. Changes in the lung IL-6 mRNA and MPO activity
(A) Total RNA from lung tissues was extracted, reverse-transcribed and examined for IL-6 
mRNA expressions by real time PCR. The fold change was calculated based on GAPDH 
levels. (B) MPO activity in the lungs. Data are expressed as mean ± SE and compared by 
one-way ANOVA and SNK test. *P<0.05 vs. Sham and #P<0.05 vs. Vehicle.
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Figure 4. Changes in apoptosis markers in the lungs
Protein lysates were subjected to Western blotting and examined for cleaved caspase-3 (A) 
and Bcl-2 (B) proteins. β-actin was used as the internal control. The ratio between the 
protein and β-actin for Sham was considered as 1.0. Data are expressed as mean ± SE and 
compared by one-way ANOVA and SNK test. *P<0.05 vs. Sham and #P<0.05 vs. Vehicle.
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Figure 5. Changes in Wnt/β-catenin signaling mediators
Protein lysates from the lungs were examined for β-catenin (A) and Cyclin-D1 (B) 
expressions. β-actin was used as the internal control. The ratio between the protein and β-
actin for Sham is considered as 1.0. Data are expressed as mean ± SE and compared by one-
way ANOVA and SNK test. *P<0.05 vs. Sham and #P<0.05 vs. Vehicle.
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Figure 6. Changes in mean arterial pressure
Recordings of arterial blood pressure during the 90 min hemorrhage and the first 50 min of 
resuscitation in Sham, Vehicle and Wnt agonist treatment.
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